Icecure medical ceo issues letter to shareholders

Caesarea, israel , jan. 4, 2023 /prnewswire/ -- icecure medical ltd. (nasdaq: iccm) (tase: iccm) ("icecure" or the "company"), developer of minimally-invasive cryoablation technology, the prosense® system that destroys tumors by freezing, today released the following letter to shareholders from its chief executive officer, eyal shamir.
MDT Ratings Summary
MDT Quant Ranking